SWOG clinical trial number
S0437
Prostate Cancer Prevention Trial (PCPT) Companion Long Term Follow Up Study for Men Diagnosed with Prostate Cancer
Closed
Phase
Accrual
53%
Abbreviated Title
PCPT Long Term Follow Up
Activated
09/01/2005
Closed
03/01/2009
Participants
PCPT Institutions with Participants who were Diagnosed with Prostate Cancer on or Before 12/31/03
Research committees
Genitourinary Cancer
Eligibility Criteria Expand/Collapse
Participants randomized in the Prostate Cancer Prevention Trial (PCPT, SWOG-9217) who were diagnosed with prostate cancer on or before December 31, 2003
Other Clinical Trials
SWOG Clinical Trial Number
S2312
A Phase III Study of Cabazitaxel with or without Carboplatin in Patients with metastatic castrate-resistant prostate cancer (mCRPC), Stratified by Aggressive Variant Signature
Research Committee(s)
Genitourinary Cancer
Activated
09/03/2024
Accrual
0%
Open
Phase
SWOG Clinical Trial Number
S2210
S2210, "Targeted Neoadjuvant Treatment for Patients with Localized Prostate Cancer and Germline DNA Repair Deficiency"
Research Committee(s)
Genitourinary Cancer
Activated
08/14/2023
Accrual
7%
Open
Phase
SWOG Clinical Trial Number
S2200
S2200, A Phase II Randomized Trial of Cabozantinib with or Without Atezolizumab in Patients with Advanced Papillary Renal Cell Carcinoma: PAPMET2
Research Committee(s)
Genitourinary Cancer
Activated
09/19/2022
Accrual
14%
Open
Phase